The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Mucocutaneous Lymph Node Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Mucocutaneous Lymph Node Syndrome


High impact information on Mucocutaneous Lymph Node Syndrome


Chemical compound and disease context of Mucocutaneous Lymph Node Syndrome


Biological context of Mucocutaneous Lymph Node Syndrome


Anatomical context of Mucocutaneous Lymph Node Syndrome


Gene context of Mucocutaneous Lymph Node Syndrome


Analytical, diagnostic and therapeutic context of Mucocutaneous Lymph Node Syndrome


  1. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. Koren, G., Rose, V., Lavi, S., Rowe, R. JAMA (1985) [Pubmed]
  2. Active or recent parvovirus B19 infection in children with Kawasaki disease. Nigro, G., Zerbini, M., Krzysztofiak, A., Gentilomi, G., Porcaro, M.A., Mango, T., Musiani, M. Lancet (1994) [Pubmed]
  3. Evaluation of myocardial ischemia in Kawasaki disease by dobutamine stress signal-averaged ventricular late potentials. Genma, Y., Ogawa, S., Zhang, J., Yamamoto, M. Cardiovasc. Res. (1997) [Pubmed]
  4. Overview of pharmacological treatment of Kawasaki disease. Onouchi, Z., Kawasaki, T. Drugs (1999) [Pubmed]
  5. The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. Takeshita, S., Nakatani, K., Kawase, H., Seki, S., Yamamoto, M., Sekine, I., Yoshioka, S. J. Infect. Dis. (1999) [Pubmed]
  6. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Foell, D., Ichida, F., Vogl, T., Yu, X., Chen, R., Miyawaki, T., Sorg, C., Roth, J. Lancet (2003) [Pubmed]
  7. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Biezeveld, M.H., Kuipers, I.M., Geissler, J., Lam, J., Ottenkamp, J.J., Hack, C.E., Kuijpers, T.W. Lancet (2003) [Pubmed]
  8. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Leung, D.Y., Cotran, R.S., Kurt-Jones, E., Burns, J.C., Newburger, J.W., Pober, J.S. Lancet (1989) [Pubmed]
  9. Tat and Kawasaki disease. Rautonen, J., Rautonen, N. Immunol. Today (1992) [Pubmed]
  10. Neuromuscular and immunochemical abnormalities in an adult man with Kawasaki disease. Hicks, J.T., Korenyi-Both, A., Utsinger, P.D., Baran, E.M., McLaughlin, G.E. Ann. Intern. Med. (1982) [Pubmed]
  11. Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography. Muzik, O., Paridon, S.M., Singh, T.P., Morrow, W.R., Dayanikli, F., Di Carli, M.F. J. Am. Coll. Cardiol. (1996) [Pubmed]
  12. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. Yamakawa, R., Ishii, M., Sugimura, T., Akagi, T., Eto, G., Iemura, M., Tsutsumi, T., Kato, H. J. Am. Coll. Cardiol. (1998) [Pubmed]
  13. Transthoracic Doppler assessment of coronary flow velocity reserve in children with Kawasaki disease: comparison with coronary angiography and thallium-201 imaging. Hiraishi, S., Hirota, H., Horiguchi, Y., Takeda, N., Fujino, N., Ogawa, N., Nakahata, Y. J. Am. Coll. Cardiol. (2002) [Pubmed]
  14. Evaluation of coronary flow velocity dynamics and flow reserve in patients with Kawasaki disease by means of a Doppler guide wire. Hamaoka, K., Onouchi, Z., Kamiya, Y., Sakata, K. J. Am. Coll. Cardiol. (1998) [Pubmed]
  15. Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Biezeveld, M.H., Geissler, J., Weverling, G.J., Kuipers, I.M., Lam, J., Ottenkamp, J., Kuijpers, T.W. Arthritis Rheum. (2006) [Pubmed]
  16. Tomographic myocardial perfusion scintigraphy in children with Kawasaki disease. Spielmann, R.P., Nienaber, C.A., Hausdorf, G., Montz, R. J. Nucl. Med. (1987) [Pubmed]
  17. Decreased protein binding of salicylates in Kawasaki disease. Koren, G., Silverman, E., Sundel, R., Edney, P., Newburger, J.W., Klein, J., Robieux, I., Laxer, R., Giesbrecht, E., Burns, J.C. J. Pediatr. (1991) [Pubmed]
  18. Assessment of left ventricular function in Kawasaki disease by dipyridamole-loading cineventriculography. Kosuda, T., Sone, K. Am. J. Cardiol. (1992) [Pubmed]
  19. Late diagnosis of Kawasaki disease is associated with haptoglobin phenotype. Lee, W.C., Hwang, K.P., King, Y.T., Chen, H.C., Chiou, S.S., Yang, R.C., Huang, T.Y. Eur. J. Clin. Invest. (2000) [Pubmed]
  20. Immunomodulation by intravenous immune globulin in Kawasaki disease. Leung, D.Y. J. Allergy Clin. Immunol. (1989) [Pubmed]
  21. Induction of MCP1, CCR2, and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease. Cheung, Y.F., O, K., Tam, S.C., Siow, Y.L. Pediatr. Res. (2005) [Pubmed]
  22. CD8 T lymphocytes do not express cytotoxic proteins in coronary artery aneurysms in acute Kawasaki disease. Guzman-Cottrill, J.A., Garcia, F.L., Shulman, S.T., Rowley, A.H. Pediatr. Infect. Dis. J. (2005) [Pubmed]
  23. Safety and efficacy of intravenous adenosine for pharmacologic stress testing in children with aortic valve disease or Kawasaki disease. Prabhu, A.S., Singh, T.P., Morrow, W.R., Muzik, O., Di Carli, M.F. Am. J. Cardiol. (1999) [Pubmed]
  24. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses. Ueno, Y., Takano, N., Kanegane, H., Yokoi, T., Yachie, A., Miyawaki, T., Taniguchi, N. Clin. Exp. Immunol. (1989) [Pubmed]
  25. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. Burns, J.C., Shimizu, C., Gonzalez, E., Kulkarni, H., Patel, S., Shike, H., Sundel, R.S., Newburger, J.W., Ahuja, S.K. J. Infect. Dis. (2005) [Pubmed]
  26. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Kariyazono, H., Ohno, T., Khajoee, V., Ihara, K., Kusuhara, K., Kinukawa, N., Mizuno, Y., Hara, T. Pediatr. Res. (2004) [Pubmed]
  27. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Hirao, J., Hibi, S., Andoh, T., Ichimura, T. Int. Arch. Allergy Immunol. (1997) [Pubmed]
  28. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease. Wong, M., Silverman, E.D., Fish, E.N. J. Rheumatol. (1997) [Pubmed]
  29. Evidence for immunosuppression by high-dose gammaglobulin. Kawada, K., Terasaki, P.I. Exp. Hematol. (1987) [Pubmed]
  30. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. Furukawa, S., Matsubara, T., Umezawa, Y., Okumura, K., Yabuta, K. J. Pediatr. (1994) [Pubmed]
  31. Detection of myocardial contractile reserve by low-dose dobutamine quantitative gated single-photon emission computed tomography in patients with Kawasaki disease and severe coronary artery lesions. Karasawa, K., Miyashita, M., Taniguchi, K., Kanamaru, H., Ayusawa, M., Noto, N., Sumitomo, N., Okada, T., Harada, K. Am. J. Cardiol. (2003) [Pubmed]
  32. High serum levels of M-CSF and G-CSF in Kawasaki disease. Igarashi, H., Hatake, K., Tomizuka, H., Yamada, M., Gunji, Y., Momoi, M.Y. Br. J. Haematol. (1999) [Pubmed]
  33. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease. Kuniyuki, S., Asada, M. J. Am. Acad. Dermatol. (1997) [Pubmed]
WikiGenes - Universities